(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IMPLAVAX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

IMPLAVAX

ST13

US500000079296059

Class

42

Filing

79296059

Registration

6458326

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

02/28/2022

Trademark type

Word

Nice classes

42

Filing date

09/03/2020

Registration date

08/24/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/24/2021

Last transaction

02/03/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

GB

Examiner

PARK, JENNY K

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Enesi Pharma Limited

Representatives

Rebecca Liebowitz Venable LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Medical and veterinary research and development services; medical and veterinary device development services; pharmaceutical drug and vaccine development services; pharmaceutical drug and vaccine delivery system development services; preparation and/or formulation of pharmaceuticalspharmaceutical drug and vaccine development services; scientific research into vaccines; medical and veterinary device and product testing services; provision of information relating to the aforesaid servicesmedical and veterinary research and development servicesmedical and veterinary device development servicespharmaceutical drug and vaccine development servicespharmaceutical drug and vaccine delivery system development servicespharmaceutical drug and vaccine development servicesscientific research into vaccines and medical and veterinary device and product testing services; consultancy in relation to the aforesaid servicesmedical and veterinary research and development servicesmedical and veterinary device development servicespharmaceutical drug and vaccine development servicespharmaceutical drug and vaccine delivery system development servicespharmaceutical drug and vaccine development servicesscientific research into vaccines and medical and veterinary device and product testing services; none of the aforesaid services relating to the treatment of cancer

Publications

History of USPTO decisions and trademark events.

25 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/28/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/04/2022

FIMP

FINAL DISPOSITION PROCESSED

02/03/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/24/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

08/24/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/08/2021

PUBO

PUBLISHED FOR OPPOSITION

06/08/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/19/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/03/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/27/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/26/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/26/2021

ATRV

ATTORNEY REVIEW COMPLETED

03/22/2021

LIME

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

03/22/2021

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

01/08/2021

RFNT

REFUSAL PROCESSED BY IB

12/20/2020

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

12/11/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/01/2020

RFRR

REFUSAL PROCESSED BY MPU

12/01/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/10/2020

CNRT

NON-FINAL ACTION WRITTEN

11/09/2020

DOCK

ASSIGNED TO EXAMINER

11/02/2020

MAFR

APPLICATION FILING RECEIPT MAILED

10/23/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/19/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/15/2020

Continuous trademark protection

Get notified about every new filing that threatens IMPLAVAX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.